These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 22481216)
1. PR3 antibodies do not induce renal pathology in a novel PR3-humanized mouse model for Wegener's granulomatosis. Relle M; Cash H; Schommers N; Reifenberg K; Galle PR; Schwarting A Rheumatol Int; 2013 Mar; 33(3):613-22. PubMed ID: 22481216 [TBL] [Abstract][Full Text] [Related]
2. Renal involvement in Wegener's granulomatosis. Renaudineau Y; Le Meur Y Clin Rev Allergy Immunol; 2008 Oct; 35(1-2):22-9. PubMed ID: 18172777 [TBL] [Abstract][Full Text] [Related]
3. Correlation of antineutrophil cytoplasmic antibodies with the extrarenal histopathology of Wegener's (pathergic) granulomatosis and related forms of vasculitis. Fienberg R; Mark EJ; Goodman M; McCluskey RT; Niles JL Hum Pathol; 1993 Feb; 24(2):160-8. PubMed ID: 8381764 [TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of a capture ELISA for detection of proteinase-3 antineutrophil cytoplasmic antibody. Westman KW; Selga D; Bygren P; Segelmark M; Baslund B; Wiik A; Wieslander J Kidney Int; 1998 May; 53(5):1230-6. PubMed ID: 9573537 [TBL] [Abstract][Full Text] [Related]
5. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive and ANCA-Negative Patients With Granulomatosis With Polyangiitis (Wegener's): Distinct Patient Subsets. Miloslavsky EM; Lu N; Unizony S; Choi HK; Merkel PA; Seo P; Spiera R; Langford CA; Hoffman GS; Kallenberg CG; St Clair EW; Tchao NK; Fervenza F; Monach PA; Specks U; Stone JH Arthritis Rheumatol; 2016 Dec; 68(12):2945-2952. PubMed ID: 27428559 [TBL] [Abstract][Full Text] [Related]
6. Discrimination and variable impact of ANCA binding to different surface epitopes on proteinase 3, the Wegener's autoantigen. Silva F; Hummel AM; Jenne DE; Specks U J Autoimmun; 2010 Dec; 35(4):299-308. PubMed ID: 20810247 [TBL] [Abstract][Full Text] [Related]
7. Lessons from a double-transgenic neutrophil approach to induce antiproteinase 3 antibody-mediated vasculitis in mice. Schreiber A; Eulenberg-Gustavus C; Bergmann A; Jerke U; Kettritz R J Leukoc Biol; 2016 Dec; 100(6):1443-1452. PubMed ID: 27365530 [TBL] [Abstract][Full Text] [Related]
8. Anti-proteinase 3 anti-neutrophil cytoplasm autoantibodies recapitulate systemic vasculitis in mice with a humanized immune system. Little MA; Al-Ani B; Ren S; Al-Nuaimi H; Leite M; Alpers CE; Savage CO; Duffield JS PLoS One; 2012; 7(1):e28626. PubMed ID: 22247758 [TBL] [Abstract][Full Text] [Related]
17. A critical evaluation of commercial immunoassays for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase in Wegener's granulomatosis and microscopic polyangiitis. Csernok E; Ahlquist D; Ullrich S; Gross WL Rheumatology (Oxford); 2002 Nov; 41(11):1313-7. PubMed ID: 12422006 [TBL] [Abstract][Full Text] [Related]
18. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive Granulomatosis With Polyangiitis (Wegener's) Is a Clinically Distinct Subset of ANCA-Associated Vasculitis: A Retrospective Analysis of 315 Patients From a German Vasculitis Referral Center. Schirmer JH; Wright MN; Herrmann K; Laudien M; Nölle B; Reinhold-Keller E; Bremer JP; Moosig F; Holle JU Arthritis Rheumatol; 2016 Dec; 68(12):2953-2963. PubMed ID: 27333332 [TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of classical and atypical antineutrophil cytoplasmic antibody (ANCA) immunofluorescence patterns. Wong RC; Silvestrini RA; Savige JA; Fulcher DA; Benson EM J Clin Pathol; 1999 Feb; 52(2):124-8. PubMed ID: 10396240 [TBL] [Abstract][Full Text] [Related]
20. Are anti-proteinase-3 ANCA a useful marker of granulomatosis with polyangiitis (Wegener's) relapses? Results of a retrospective study on 126 patients. Thai LH; Charles P; Resche-Rigon M; Desseaux K; Guillevin L Autoimmun Rev; 2014 Mar; 13(3):313-8. PubMed ID: 24225075 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]